Bharvin K.R. Patel

γ-Secretase inhibition increases efficacy of BCMA-specific chimeric antigen receptor T cells in multiple myeloma

Margot J. Pont, Tyler Hill, Gabriel O. Cole et al. · Blood · 2019 · 310 citations · Full text

First-in-human study of LY3039478, an oral Notch signaling inhibitor in advanced or metastatic cancer

Christophe Massard, A. Ázaro, Jean‐Charles Soria et al. · Annals of Oncology · 2018 · 159 citations · Full text

Antisense Inhibition of Survivin Expression as a Cancer Therapeutic

Rosa A. Carrasco, Nancy B. Stamm, Eric G. Marcusson et al. · Molecular Cancer Therapeutics · 2011 · 125 citations · Full text

Survivin Antisense Oligonucleotide, Oncology, Chemoprevention Strategy +15

Regulation of the human poly(ADP-ribose) polymerase promoter by the ETS transcription factor

Viatcheslav A. Soldatenkov, Amador Albor, Bharvin K.R. Patel et al. · Oncogene · 1999 · 91 citations

Transcriptional Regulation, Protein Expression, Natural Sciences +12

A first-in-human phase I study of the oral Notch inhibitor, LY900009, in patients with advanced cancer

Shubham Pant, Suzanne F. Jones, Carla Kurkjian et al. · European Journal of Cancer · 2016 · 89 citations